Latest imports
$26.2MReported valueHS6 Product Import Market
DOM imports of Vaccines: for human medicine (HS 300220)
A complete buyer-market view for HS 300220, covering reported demand, import growth, supplier countries, market concentration, trade routes, and historical context.
Three-year growth
-59.7%Annualized changeSupplier countries
18Latest reported countMarket concentration
2531.70HHI indicatorMarket evidence
How large is the DOM HS 300220 market?
This profile combines the buyer market's reported size and growth with supplier and route observations for Vaccines: for human medicine.
| Measure | Reported value | What it indicates |
|---|---|---|
| Latest imports | $26.2M | Import value in the latest available year |
| Three-year annualized growth | -59.7% | Change in reported import value |
| Three-year average imports | $19.2M | Average reported annual import value |
| Supplier countries | 18 | Distinct suppliers reported in the latest period |
| Market concentration | 2531.70 | HHI indicator based on supplier shares |
| Demand momentum | Accelerating demand | Direction reported for this market |
Supplier evidence
Who supplies DOM?
Leading supplier routes for this product and importing country, ranked by latest reported trade value.
| Supplier | Route trade | Three-year growth | Market share | Trend | Attention |
|---|---|---|---|---|---|
| Supplier route observations are not available. | |||||
Market reading
What does this buyer market show?
DOM reported imports of vaccines: for human medicine at $26.2M in the latest available observation, with three-year annualized change of -59.7%.
How to use this view
Compare supplier scale, market share, and growth together. A large supplier is not automatically a growing supplier, and a growing market does not guarantee commercial access.
Interpretation
How to assess this buyer market
Start with the size of reported imports, then compare the pace of change with supplier breadth. A concentrated market may be harder to enter but can reveal established supply relationships; a broad supplier base may offer more room for differentiated positioning.
Compare the route, not only the country
Supplier totals describe the market at country level. Route evidence can reveal which exporter-to-importer relationships account for the observed value and where supplier activity is changing.
Product classification
What does HS 300220 include?
HS 300220 covers Vaccines: for human medicine. This page describes the six-digit Harmonized System classification and reported merchandise imports, not company-level sales or individual shipments.
The classification belongs to HS chapter 30 and heading 3002. Use the code when comparing this market with related product classifications.
How to interpret this market
Compare demand, suppliers, and routes together
DOM's reported imports of vaccines: for human medicine show the size of the buyer market. Supplier breadth and concentration add context, while route-level observations show which exporter-to-importer relationships account for the reported value.
A growing market does not guarantee commercial access, and a large supplier is not automatically the fastest-growing supplier. Read the current value together with the historical coverage, supplier share, and trend indicators.
Source and date
Reported merchandise-trade observations for HS6 300220. Coverage shown on this page: 1995-2024.
Definitions
Market share and growth are calculated from reported values where available. “Not reported” means the value was unavailable for this view.
Related view
Compare Vaccines: for human medicine across buyer markets.
Read the methodology before comparing markets.